Department of Oncology and Pathology, Cancer Center Karolinska, Stockholm, Sweden.
Oncogene. 2012 Jan 19;31(3):352-65. doi: 10.1038/onc.2011.239. Epub 2011 Jun 20.
The human cathelicidin antimicrobial protein-18 and its C terminal peptide, LL-37, displays broad antimicrobial activity that is mediated through direct contact with the microbial cell membrane. In addition, recent studies reveal that LL-37 is involved in diverse biological processes such as immunomodulation, apoptosis, angiogenesis and wound healing. An intriguing role for LL-37 in carcinogenesis is also beginning to emerge and the aim of this paper was to explore if and how LL-37 contributes to the signaling involved in tumor development. To this end, we investigated the putative interaction between LL-37 and growth factor receptors known to be involved in tumor growth and progression. Among several receptors tested, LL-37 bound with the highest affinity to insulin-like growth factor 1 receptor (IGF-1R), a receptor that is strongly linked to malignant cellular transformation. Furthermore, this interaction resulted in a dose-dependent phosphorylation and ubiquitination of IGF-1R, with downstream signaling confined to the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK)-pathway but not affecting phosphatidylinositol 3 kinase/Akt signaling. We found that signaling induced by LL-37 was dependent on the recruitment of β-arrestin to the fully functional IGF-1R and by using mutant receptors we demonstrated that LL-37 signaling is dependent on β-arrestin-1 binding to the C-terminus of IGF-1R. When analyzing the biological consequences of increased ERK activation induced by LL-37, we found that it resulted in enhanced migration and invasion of malignant cells in an IGF-1R/β-arrestin manner, but did not affect cell proliferation. These results indicate that LL-37 may act as a partial agonist for IGF-1R, with subsequent intra-cellular signaling activation driven by the binding of β-arrestin-1 to the IGF-1R. Functional experiments show that LL-37-dependent activation of the IGF-1R signaling resulted in increased migratory and invasive potential of malignant cells.
人源抗菌肽 cathelicidin-18 及其 C 端肽 LL-37 可通过与微生物细胞膜直接接触发挥广谱抗菌活性。此外,最近的研究揭示了 LL-37 参与多种生物学过程,如免疫调节、细胞凋亡、血管生成和伤口愈合。LL-37 在肿瘤发生中的作用也引起了人们的关注,本文旨在探讨 LL-37 是否以及如何参与肿瘤发展相关的信号转导。为此,我们研究了推测的 LL-37 与已知参与肿瘤生长和进展的生长因子受体之间的相互作用。在测试的几种受体中,LL-37 与胰岛素样生长因子 1 受体(IGF-1R)结合的亲和力最高,IGF-1R 与恶性细胞转化密切相关。此外,这种相互作用导致 IGF-1R 的磷酸化和泛素化呈剂量依赖性,下游信号局限于丝裂原活化蛋白激酶/细胞外信号调节激酶(ERK)途径,但不影响磷脂酰肌醇 3 激酶/蛋白激酶 B(Akt)信号。我们发现,LL-37 诱导的信号转导依赖于β-arrestin 募集到功能齐全的 IGF-1R 上,并且使用突变受体,我们证明了 LL-37 信号转导依赖于β-arrestin-1 与 IGF-1R 的 C 末端结合。在分析由 LL-37 引起的 ERK 激活增加的生物学后果时,我们发现它以 IGF-1R/β-arrestin 方式增强了恶性细胞的迁移和侵袭,但不影响细胞增殖。这些结果表明,LL-37 可能作为 IGF-1R 的部分激动剂,随后通过β-arrestin-1 与 IGF-1R 的结合来驱动细胞内信号转导激活。功能实验表明,LL-37 依赖性 IGF-1R 信号转导的激活导致恶性细胞迁移和侵袭潜能增加。